BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoodLifeSci - ECPv6.18.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GoodLifeSci
X-ORIGINAL-URL:https://goodlifesci.sidley.com
X-WR-CALDESC:Events for GoodLifeSci
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260923
DTSTAMP:20260901T160759Z
CREATED:20260507T155633Z
LAST-MODIFIED:20260901T160759Z
UID:2718-1790035200-1790121599@goodlifesci.sidley.com
SUMMARY:Sidley Healthcare Investment Conference 2026
DESCRIPTION:As dealmaking and investment continue to shape the future of life sciences and healthcare\, Sidley will convene senior leaders from pharma\, biotech\, healthcare\, private equity\, and venture capital to explore the forces defining the year ahead. \n \nRSVP here. \nJoin Sidley and industry decision-makers from around the world\, including from Agomab\, Astellas Pharma\, AstraZeneca\, AviadoBio\, Caidya\, Eurazeo Capital\, Flagship Pioneering\, GSK\, Harbinger Health\, J.P. Morgan\, Labcorp\, LetterOne Health\, Monograph Capital and Sanofi for this one-day\, in-person program in London. Virtual attendance is available for those joining from outside the UK. \nExpect a day of sharp insights\, dynamic discussion\, and valuable networking as we explore how the continued convergence of innovation and capital is driving positive patient outcomes and investment returns. \nPanels will include: \n\nGo West? European Biotech Innovation: U.S. Exits\nHealthcare M&A and Buyouts: State of the Market\nThe AI Imperative: Reshaping Drug Development and Investment\nThe Rise of China: A Partner\, Not a Rival\n\nView the Sidley Healthcare Investment Conference 2025 highlights.
URL:https://goodlifesci.sidley.com/event/sidley-healthcare-investment-conference-2026/
LOCATION:The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, UK\, The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20261110T173000
DTEND;TZID=Europe/Zurich:20261110T210000
DTSTAMP:20260826T194104Z
CREATED:20260826T194104Z
LAST-MODIFIED:20260826T194104Z
UID:2864-1794331800-1794344400@goodlifesci.sidley.com
SUMMARY:A New World Order – Market Access\, MFN\, and Geopolitics
DESCRIPTION:Sidley’s Women’s Life Sciences Network (WLSN) is pleased to invite you to its upcoming Swiss event\, bringing together leading professionals from across the life sciences sector for a discussion on key legal and policy developments. From MFN pricing pressures to shifting geopolitical fault lines\, the rules shaping market access are being rewritten. Join us as we explore what this new world order means for life sciences companies operating across borders. \n \nFeatured speakers: \n– Kelley Friedgen\, Head Legal Counsel\, One Pharma Strategy\, Roche\n– Mareike Ostertag\, Executive Director\, Cembramo Advisors\, Special Advisor to the Director General of IFPMA \nAGENDA\n5:30 p.m. – Arrival and registration\n6:00 p.m. – Panel discussion and Q&A\n7:30 p.m. – Networking and apéro riche \nFor more information\, please contact brevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/a-new-world-order-market-access-mfn-and-geopolitics/
LOCATION:Grand Hotel Les Trois Rois\, Blumenrain 8\, CH-4001\, Basel\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20261202T140000
DTEND;TZID=Europe/Zurich:20261202T180000
DTSTAMP:20261012T155905Z
CREATED:20261012T155723Z
LAST-MODIFIED:20261012T155905Z
UID:2926-1796220000-1796234400@goodlifesci.sidley.com
SUMMARY:Good Manufacturing Practice 2026: Regulatory Reliance\, AI and Global GMP
DESCRIPTION:Join us in Basel for Sidley’s 2026 GMP Event\, bringing together regulators\, industry leaders\, and practitioners for an international discussion on the latest developments shaping pharmaceutical manufacturing\, quality\, and compliance. \n \nRSVP here. \nThe discussions will look across Switzerland\, the EU\, and the United States at evolving regulatory expectations\, inspection and enforcement trends\, manufacturing and supply-chain challenges\, and the technologies transforming GMP-regulated operations. \nFeatured Speakers and Panelists\n \n– Christian Schärer\, Head of Inspectorates\, Swissmedic\n– Viktor Mettler\, Digital Quality Lead\, Takeda \nKey Insights\n \n– Reliance\, Mutual Recognition\, and Inspection Perspectives\nExplore the growing role of regulatory reliance and mutual recognition in GMP oversight and inspections\, alongside inspection and enforcement trends\, evolving regulatory expectations\, and manufacturing and supply-chain challenges across Switzerland\, the EU\, and the United States. \n– Innovation\, Digital Transformation\, and AI\nDiscover how advanced manufacturing\, automation\, digital technologies\, and AI are transforming pharmaceutical production and quality systems – and the evolving regulatory expectations around validation\, data integrity\, governance\, and regulatory oversight. \n– Looking Ahead\nUnderstand key regulatory developments\, emerging technologies\, and broader industry trends that are likely to shape GMP compliance and pharmaceutical manufacturing in 2027 and beyond. \nWho Should Attend?\nExecutives\, in-house counsel\, quality and compliance managers and officers interested in and/or facing GMP compliance and quality management challenges in Switzerland.
URL:https://goodlifesci.sidley.com/event/good-manufacturing-practice-2026-regulatory-reliance-ai-and-global-gmp/
LOCATION:Memox\, Peter-Merian Strasse 80\, Basel\, 4052\, Switzerland
END:VEVENT
END:VCALENDAR